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g.2013.1Abstract Background: Allgrove or AAA (Triple A) syndrome is a rare autosomal recessive dis-
ease characterized by achalasia, alacrima, adrenocorticotrophic insufﬁciency and some neurologic
abnormalities.
Case report: Here we report two brothers 13 and 15 years old, with variable features of the syn-
drome, with prominent neurological symptoms which started in the ﬁrst decade and, led to motor
paralysis and severe muscle wasting in the elderly brother in the second decade of life. Moderate
achalasia developed at 9 years in the older brother and showed a slowly progressive course with
development of chest pain and dysphagia. Alacrima was not evident before the age of 12 years.
The neurological symptoms were less severe in the younger brother. He suffered alacrima that
started at age of 11 years and mild dysphagia due to achalasia at age of 12 years, both being slowly
progressive.
This paper highlights early features of this syndrome among Egyptian population and the impor-
tance to exclude Allgrove syndrome in the presence of progressive neurological dysfunction.
To conclude: Allgrove syndrome should be suspected in patients with neurological impairment
associated with any of the main symptoms of the syndrome (alacrima, achalasia and adrenal insuf-
ﬁciency).
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Allgrove’s syndrome is a rare autosomal recessive disorder,
which is characterized by many features with alacrima, achala-ax: +20 2 33370931.
.
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0.003sia, autonomic disturbance, and ACTH insensitivity being the
common features [1]. Other features that may present during
the ﬁrst decade of life include severe (occasionally fatal) hypo-
glycaemic or hypotensive attacks, related to adrenocortical
insufﬁciency. Cholinergic dysfunction and autonomic tests
are usually disturbed with a signiﬁcant deviation from normal
values [2].
Sometimes adrenal insufﬁciency or other features may be
delayed to adulthood, but adult cases with Allgrove’s syn-
drome commonly present with neurological disease that affects
multiple neurological systems [3].in Shams University.
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central, peripheral and autonomic nervous system [4,5]. Seri-
ous reported neurological manifestations include dementia,
Wernicke’s encephalopathy [6], optic atrophy, cerebellar atax-
ia, and Parkinsonism [7].
The syndrome has been mapped to a 6 cm interval on chro-
mosome 12q13 [8]. The disease is thought to be caused by
mutation in the AAAS gene on chromosome 12q13, which en-
codes ALADIN protein (a part of the nuclear pore complex),
resulting in an impaired protein function. Other changes in the
AAAS gene include a missense mutation p.R155H, c.618delC,
and p.Ser207fs [9].
The exact biological effect of the impaired ALADIN pro-
tein is unknown, some evidence showed that the ﬁbroblasts
of 4A syndrome patients have a higher basal reactive oxygen
species (ROS) level and an increased level with an increased
sensitivity to oxidative stress [10]. Further studies are still
needed to elucidate the precise cellular/molecular pathways
that are disturbed in this disorder.
The aim of this case report is to describe two Egyptian
brothers with Allgrove syndrome, with different clinical pre-
sentation and different age of the onset.
Consent of the parents as well as the ethics committee of the
National Research Centre (NRC) was obtained.
2. Case report
Here we describe a family who has two diseased male siblings,
and parents are ﬁrst cousins (Fig. 1). They are 13 and 15 years
old and the symptoms started around the age of 6–7 years (Ta-
ble 1). In the older brother, impaired sensation and progressive
muscle weakness (more prominent in lower limbs) started at
7 years. Then ataxic gait developed at around 12 years with
progressive muscle wasting, lost deep reﬂexes, mildly impaired
superﬁcial reﬂexes and development of ataxic gait. Eye exam-
ination showed mild corneal dryness, normal fundus and vi-
sual evoked potential.
In the younger brother neurological symptoms started at
the age of 9 years with impaired muscle power and superﬁcial
sensations in the lower limbs with mild affection in the upperDistant 
cousins
First degree cousins
15
years
13 years
Figure 1 Pedigree of the family with two siblings having
Allgrove syndrome.limbs. The course was slowly progressive until the age of
13 years with decreased muscle tone and development of ataxic
gait (other cerebellar signs are not prominent). Eye examina-
tion showed normal fundus and visual evoked potential
(VEP). Cranial nerves were intact in both cases.
Mixed axonal and dendritic peripheral neuropathy signs
are evident by nerve conduction tests (NCT). Achalasia is pres-
ent in both cases and started in the ﬁrst decade of life being
moderately progressive and then chest pain developed in the
older brother. Alacrima is present in the older case and is
mildly detected in his brother. Genital examination revealed
small testicles and penis with sparse pubic and axillary hair
(stage 2 puberty), reﬂecting adrenocortical insufﬁciency. Rest-
ing blood pressure was within normal ranges with slightly im-
paired pressor test and standing blood pressure.
Some dysmorphic features were seen; low set ears, short
neck, down slanting palpebral ﬁssures of the eyes, low poster-
ior hairline. Dermatological signs in the form of hyperkerato-
sis of palms, low inserted thumb are present in the younger
brother (in both hands). In the older brother, short neck and
low posterior hairline were seen.
3. Discussion
The prevalence of Allgrove syndrome is unknown, only scat-
tered family and case reports were noted in the literature. An
autosomal recessive inheritance of Allgrove syndrome is sus-
pected with variable presentation. No evidence suggests that
gender affects the frequency.
The three main features of the disease are adrenal insufﬁ-
ciency (presented by hypoglycaemia or hypotension), alacrima
that leads if severe to keratopathy and corneal melting and
achalasia leading to frequent vomiting or regurgitation. Alac-
rima was considered the most early and consistent feature [11].
It is worth mentioning that previous follow up studies for chil-
dren with dysphagia and symptoms of achalasia revealed most
cases as isolated cases without other symptoms of Allgrove
syndrome, while alacrima being a more constant feature [12].
In Allgrove syndrome, usually normal ACTH level is found
in blood while cortisol level is subnormal and/or showing dis-
turbances in diurnal variation, which is explained by ACTH
resistance [13]. Our cases show normal ACTH and decreased
morning and evening cortisol level in blood.
A factor that also plays a role in the difﬁcult determination
of the prevalence of the syndrome is its variable presentation,
including unexplained childhood death due to adrenal crisis or
mild disease that is not apparent until adulthood. Develop-
mental delay could be the sole prominent presentation of the
syndrome.
The cases presented in this study showed the features of All-
grove syndrome during ﬁrst decade in life with the neurological
symptoms being the earliest manifestation, with decreased
muscle power, sensation and deep reﬂexes in both brothers
(more progressive in the elderly sib). In addition, cerebellar
signs were clear.
Minimal signs of autonomic neuropathy are present in both
sibs. Although, alacrima and achalasia developed over a slowly
progressive course, they were overlooked by the signiﬁcant
neurological impairment.
The neurological disturbances associated with Allgrove
syndrome are variable and a previous study showed that all
Table 1 Clinical ﬁndings and investigations in the 2 Allgrove cases.
Case 1 Case 2
History
Age 15 years 13 years
Achalasia +ve (moderate) +ve (mild)
Alacrima (conﬁrmed by Schirmer test
[15])
+ve (moderate) +ve (mild)
Neurological symptoms
Motor power Grade II Grade III
Sensation ﬂﬂ in lower limbs ﬂ in lower limbs (LL)
Muscle tone ﬂ Moderately ﬂ mildly
Muscle wasting Severe Moderate
Superﬁcial reﬂexes ﬂ Mildly Intact
Deep reﬂexes Lost ankle, ﬂ knee Lost ankle
Cranial nerves Normal Normal
Cerebellar signs +ve (ataxic gait, ﬁnger to nose and
heel to chin test)
+ve (ataxic gait, mildly
other tests)
Fundus Normal Normal
Cardiovascular autonomic: lying BP–
standing BP
130/85–125/85 120/75–125/65
Pressor tests
Cutaneous cold: lying BP–standing BP 125/85–120/85 125/70–115/75
HR 75–85 73–80
Exercise stimulation (lying BP–standing
BP)
130/85–125/85 135/75–105/70
Investigations
Serum cortisol
Morning(AM) 2.2 lg/dL (n> 4.0) <1.0 lg/dL (n> 4.0)
Evening (PM) 1.6 lg/dL (n> 3.0) 1.2 lg/dL (n> 3.0)
Serum ACTH
AM 25 pg/ml (n< 50) 22.9 pg/ml (n< 50)
PM 27.7 pg/ml (n< 40) 26.8 pg/ml (n< 40)
Electromyography(EMG): biceps–
triceps–tibialis ant-quadriceps
Duration polyphasic action
potential (AP), ﬂ interface
Fibrillations, › duration
polyphasic AP
Nerve conduction study (NCS) ﬂ Amplitude ﬂ Amplitude and
ﬂ Nerve conduction velocity
(NCV) in UL nerves
NCV in UL and LL.
Absent in LL nerves (e.g. tibial n.)
Karyotype Normal Normal
BP stands for blood pressure, HR stands for heart rate, NCV stands for nerve conduction velocity, NCV stands for nerve conduction velocity,
AP stands for action potential.
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sensory disturbance and autonomic dysfunction were repre-
sented in 29% and 57% of patients successively [7]. A previous
Egyptian study reported myopathy in a 13 year old boy with
Allgrove syndrome [14].
Although our cases do not show prominent clinical auto-
nomic dysfunction, they were diagnosed as Allgrove syndrome
due to a combination of neurological dysfunction, alacrima
and achalasia. Laboratory tests conﬁrmed decreased cortisol
level (adrenocortical insufﬁciency).
Increased awareness of the disease speciﬁc symptoms and
signs is required for proper diagnosis, to avoid the serious
manifestations reported which include hypoglycaemia due to
adrenocortical insufﬁciency, and shock due to autonomic neu-
ropathy and adrenocortical insufﬁciency.
Our data suggest a careful assessment of children with mul-
tisystem neurological disturbances. Allgrove syndrome shouldbe suspected in patients with multiple aspects of neurological
impairment.
It should be especially considered in patients who show a
combined phenotype of motor neuron disease, sensory/auto-
nomic disturbance, and cerebellar signs, as the symptoms of
the syndrome would start with mild severity in the ﬁrst decade
of life and then progress rapidly leading to severe neurological
impairment and handicap.
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